BEAT BIOTHERAPEUTICS
BEAT BioTherapeutics Corp. (BEATBio) is a Seattle, WA based biotechnology company founded to develop novel therapies for heart disease. BEAT Bio’s first product is based on a fundamental discovery in cardiac muscle contraction and the development of a novel GeneTherapy to improve cardiac performance in the setting of heart failure.
BEAT BIOTHERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2008-01-01
Address:
Bellevue, Washington, United States
Country:
United States
Website Url:
http://www.beatbiotherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
2065430586
Email Addresses:
[email protected]
Total Funding:
2.5 M USD
Technology used in webpage:
Domain Not Resolving Google Font API Pound Sterling Japanese Yen
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Aperture Therapeutics
Aperture Therapeutics develops novel therapies for neurodegenerative diseases, leveraging genetic diversity.
C4 Therapeutics
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Lysosomal Therapeutics
Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Tacere Therapeutics
Tacere Therapeutics develops therapies to identify and treat diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
W Fund
W Fund investment in Seed Round - BEAT BioTherapeutics
CET Capital Partners
CET Capital Partners investment in Seed Round - BEAT BioTherapeutics
Official Site Inspections
http://www.beatbiotherapeutics.com
Unable to get host informations!!!
More informations about "BEAT BioTherapeutics"
BEAT Biotherapeutics Company Profile 2024: Valuation, Funding ...
BEAT Biotherapeutics General Information Description. Developer of novel therapies designed to treat heart failures. The company's therapies are used to treat heart failures by increasing …See details»
BEAT BioTherapeutics Corp - Company Profile and News
BEAT BioTherapeutics Corporation (BEATBio) develops and publishes therapies for the treatment of heart failure. The Company develops therapies based on a naturally occurring enzyme that …See details»
BEAT BioTherapeutics - VentureRadar
"BEAT BioTherapeutics is developing BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. BEATBio holds worldwide rights to this technology …See details»
BEAT BioTherapeutics Corp.: Drug pipelines, Patents, Clinical trials ...
Explore BEAT BioTherapeutics Corp. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Technology Platform:AAV based gene ...See details»
BEAT BioTherapeutics - Overview, News & Similar companies
BEAT BioTherapeutics Corp. (BEATBio) is a Seattle, WA based biotechnology company founded to develop novel therapies for heart disease. BEAT Bios f irst product is based on a …See details»
BEAT BioTherapeutics - Funding, Financials, Valuation & Investors
BEAT BioTherapeutics is funded by 2 investors. W Fund and CET Capital Partners are the most recent investors. Which investors participated in the most funding rounds?See details»
BEAT BioTherapeutics - Products, Competitors, Financials, …
BEAT BioTherapeutics Announces Scientific Presentation at American Society of Gene and Cell Therapy Annual Meeting. May 3, 2016. BEAT BioTherapeutics Announces Scientific …See details»
BEAT BioTherapeutics - Contacts, Employees, Board Members
Organization. BEAT BioTherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... BEAT BioTherapeutics has 1 …See details»
BEAT BioTherapeutics’ BB-R12 Provides Significant ... - BioSpace
Jun 4, 2015 BEAT BioTherapeutics Corporation Michael Kranda, 425-647-4236 CEO [email protected] or Sam L. Teichman, 925 437-2067 CMO …See details»
BEAT Bio Therapeutics - CoMotion
Jan 1, 2012 BEAT BioTherapeutics is developing BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. BEATBio holds worldwide rights to this technology and its UW founders are recognized …See details»
BEAT BioTherapeutics Corporation Closes $2.5MM Seed Financing …
April 16, 2013 BEAT BioTherapeutics Corporation Closes $2.5MM Seed Financing to Develop Its Gene Therapy Treatment for Heart Failure University of Washington spin-out aims to refuel …See details»
BEAT BioTherapeutics Corporation Closes $2.5MM Seed Financing …
Apr 16, 2013 BEAT BioTherapeutics closes $2.5MM seed financing to develop its gene therapy treatment for heart failure. Funding will be used to move BEATBio’s leadSee details»
BEAT BioTherapeutics - Crunchbase
BEAT BioTherapeutics develops novel therapies for heart diseases.See details»
BEAT BioTherapeutics Corporation Closes $2.5 Million Seed
Apr 16, 2013 SEATTLE--(BUSINESS WIRE)--BEATBio, a Seattle, Wash.-based biotechnology company focused on the development of a novel gene therapy to improve cardiac …See details»
BEAT BioTherapeutics Announces Scientific Presentations of …
Nov 14, 2014 BEATBio Michael Kranda, CEO, 425-647-4236 (mobile) [email protected] or Sam L. Teichman, CMO, 925-437-2067 (mobile) …See details»
Research programme: gene therapy - BEAT BioTherapeutics
BEAT BioTherapeutics, a spin-off company from the University of Washington, is developing BB R12 gene therapy for the treatment of heart failure. The therapy isSee details»
Buddy Ratner - Scientific Co-Founder @ BEAT BioTherapeutics ...
Primary Organization . BEAT BioTherapeutics . Location Bellevue, Washington, United States; Regions Greater Seattle Area, West Coast, Western US; Gender Male; cientific co-founder …See details»
Beat Therapeutics - PitchBook
Beat Therapeutics General Information Description. Operator of a biotech company intended to modify cancer treatment. The company develops DNA Damage Response (DDR) therapies to …See details»
BEAT Therapeutics - LinkedIn
New Talent at BEAT Therapeutics We are excited to announce three new students joining us, bringing a wealth of talent to our team! Inês Mota has been awarded an FCT scholarship to …See details»